Combining Clarivate’s robust proprietary data with extensive bespoke consulting and custom research capabilities, we develop nuanced, defendable assessments and strategies to help biopharmaceutical and MedTech clients make better, more informed decisions in a rapidly changing landscape.

By harnessing deep domain knowledge, proprietary data sets, and broad methodological capabilities, we provide innovative problem-solving approaches to biopharma and medtech’s toughest challenges. Our pioneering insight-enabled consulting model sets us apart, empowering us to focus on co-creation, thought partnership, and custom solutions.​

arrow_forwardMeet our Commercial Strategy experts

Global pricing and access​ strategy

Critical to the commercial success of a product is a detailed understanding of its market access potential.  Our team’s extensive experience and proprietary data assets enable us to guide you through the evolving complexities of global reimbursement markets with thoughtful consideration of the unique dynamics at play.

​Offerings include:​

• Market sizing and access journey​
• Access landscape assessment
• Evidence generation strategy​
• BD&L access due diligence​
• Pricing, contracting, and RWE strategy
• Stakeholder engagement planning​
• Indication prioritization​
• Account engagement strategy​
• External payer/KOL validation​
• TPP testing and refinement​
• Payer value proposition and messaging strategy
• Payer archetyping and segmentation​
• Launch framework optimization ​
• Early access program support​
• Emerging markets planning​